checkAd

     754  0 Kommentare Next Generation Diabetes Therapy and Drug Delivery Market Expected to Reach $9,673 Million, Globally, by 2023 - Allied Market Research

    PORTLAND, Oregon and PUNE, India, April 20, 2017 /PRNewswire/ --

    According to a new report published by Allied Market Research, titled, "Next Generation Diabetes Therapy and Drug Delivery Market by Product Type, Demographic, Indication, End User, and Geography: Global Opportunity Analysis and Industry Forecast, 2014-2023," the global next generation diabetes therapy and drug delivery market accounted for $617 million in 2015, and is estimated to reach $9,673 million by 2023, registering a CAGR of 41.1% from 2016 to 2023. North America is the highest contributor in the next generation diabetes therapy and drug delivery market; however, Asia-Pacific is witnessing the highest growth rate.

         (Logo: http://photos.prnewswire.com/prnh/20140911/647229 )
    Next generation diabetes therapy and drug delivery devices are used to check the blood glucose levels and deliver insulin into the body. Next generation diabetes drug delivery systems, such as oral and inhalable insulin, help introduce insulin into the patient's body without causing pain and reduce the risk of skin irritation, owing to frequent use of needles. Advancements in diabetes therapy systems, such as insulin patch, continuous glucose monitoring (CGM) system, and artificial pancreas, are frequently used to detect the glucose levels and adjust the insulin levels to manage the change in glucose levels.

    Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-free-sample/2098

    Rise in the number of diabetics and the benefits of using advanced diabetic devices, such as artificial pancreas and insulin patches over conventional products, are expected to boost the growth of next generation diabetes therapy and drug delivery market. Furthermore, the increase in disposable income among the diabetic patients and technological advancement of next generation diabetic products areanticipated to fuel the market growth. The rise in healthcare expenditure in the developing countries, such as India and China, is expected to provide opportunities for market expansion. However, lack of awareness, less variability in products, and cost restrains in the developing regions are expected to hamper the market growth.

    Seite 1 von 3


    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    Next Generation Diabetes Therapy and Drug Delivery Market Expected to Reach $9,673 Million, Globally, by 2023 - Allied Market Research PORTLAND, Oregon and PUNE, India, April 20, 2017 /PRNewswire/ - According to a new report published by Allied Market Research, titled, "Next Generation Diabetes Therapy and Drug Delivery Market by Product Type, Demographic, Indication, End User, and …

    Schreibe Deinen Kommentar

    Disclaimer